{"DataElement":{"publicId":"2782511","version":"1","preferredName":"Engraftment Syndrome Symptom Present Type","preferredDefinition":"A description of engraftment syndrome symptom(s) that were present.","longName":"ENGF_SYND_SYMP_PR_TP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2782507","version":"1","preferredName":"Engraftment Syndrome Symptom Present","preferredDefinition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation._Subjective evidence of disease perceived by the patient._Being or existing in a specified place or at the specified time.","longName":"ENGF_SYND_SYMP_PRSNT","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2782505","version":"1","preferredName":"Engraftment Syndrome Symptom","preferredDefinition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.:An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.","longName":"C63324:C4876","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Engraftment Syndrome","conceptCode":"C63324","definition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"567C10C4-FFAA-489E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-09","modifiedBy":"ONEDATA","dateModified":"2008-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"567C10C4-FFB8-489E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2780141","version":"1","preferredName":"Engraftment Syndrome Symptom Type","preferredDefinition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation._Subjective evidence of disease perceived by the patient._Something distinguishable as an identifiable class based on common qualities.","longName":"ENGR_SYND_SYMP_TP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Skin rash","valueDescription":"Skin Rash","ValueMeaning":{"publicId":"2578055","version":"1","preferredName":"Skin Rash","longName":"2578055","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FDF4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-01","modifiedBy":"COOPERM","dateModified":"2017-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56172F89-773A-66E4-E044-0003BA3F9857","beginDate":"2008-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"COOPERM","dateModified":"2008-09-04","deletedIndicator":"No"},{"value":"Fever","valueDescription":"Fever","ValueMeaning":{"publicId":"2569501","version":"1","preferredName":"Fever","longName":"2569501","preferredDefinition":"Fever, also known as pyrexia, is the elevation of the body's temperature above the upper limit of normal, usually taken as 37.7 degrees C.  Most fevers are caused by infections and almost all infectious diseases cause fever. (Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fever","conceptCode":"C3038","definition":"Elevation of body temperature above normal due to inflammatory or immune responses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-05-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56172F89-7747-66E4-E044-0003BA3F9857","beginDate":"2008-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"COOPERM","dateModified":"2008-09-04","deletedIndicator":"No"},{"value":"Capillary leak syndrome","valueDescription":"Capillary Leak Syndrome","ValueMeaning":{"publicId":"2780142","version":"1","preferredName":"Capillary Leak Syndrome","longName":"2780142","preferredDefinition":"A syndrome characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Capillary Leak Syndrome","conceptCode":"C62578","definition":"A syndrome characterized by leakage of intravascular fluids into the extravascular space. This syndrome is observed in patients who demonstrate a state of generalized leaky capillaries following shock syndromes, low-flow states, ischemia-reperfusion injuries, toxemias, medications, or poisoning. It can lead to generalized edema and multiple organ failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56172F89-7756-66E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56172F89-776F-66E4-E044-0003BA3F9857","beginDate":"2008-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"COOPERM","dateModified":"2008-09-04","deletedIndicator":"No"},{"value":"Other symptom","valueDescription":"Other Symptom","ValueMeaning":{"publicId":"5084332","version":"1","preferredName":"Other Symptom","longName":"5084332","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Subjective evidence of disease perceived by the patient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26E13EC1-9012-900F-E050-BB89AD435795","latestVersionIndicator":"Yes","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26E13EC1-902B-900F-E050-BB89AD435795","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"ONEDATA","dateModified":"2015-12-14","deletedIndicator":"No"},{"value":"Transient encephalopathy","valueDescription":"Temporary Encephalopathy","ValueMeaning":{"publicId":"5084333","version":"1","preferredName":"Temporary Encephalopathy","longName":"5084333","preferredDefinition":"Not permanent; not lasting; lacking continuity or regularity.: A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Temporary","conceptCode":"C53288","definition":"Not permanent; not lasting; lacking continuity or regularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Encephalopathy","conceptCode":"C26920","definition":"A functional and/or structural disorder of the brain caused by diseases (e.g. liver disease, kidney disease), medications, chemicals, and injuries.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26E13EC1-9038-900F-E050-BB89AD435795","latestVersionIndicator":"Yes","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26E13EC1-9051-900F-E050-BB89AD435795","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"ONEDATA","dateModified":"2015-12-14","deletedIndicator":"No"},{"value":"Weight gain","valueDescription":"Weight Gain","ValueMeaning":{"publicId":"5084334","version":"1","preferredName":"Weight Gain","longName":"5084334","preferredDefinition":"An increase in total body weight.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight Gain","conceptCode":"C62754","definition":"An increase in total body weight.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26E13EC1-905B-900F-E050-BB89AD435795","latestVersionIndicator":"Yes","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26E13EC1-9074-900F-E050-BB89AD435795","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"ONEDATA","dateModified":"2015-12-14","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26E13EC1-907E-900F-E050-BB89AD435795","beginDate":"2015-12-14","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-14","modifiedBy":"ONEDATA","dateModified":"2015-12-14","deletedIndicator":"No"},{"value":"Non-cardiogenic pulmonary edema","valueDescription":"Noncardiogenic Pulmonary Edema","ValueMeaning":{"publicId":"5096251","version":"1","preferredName":"Noncardiogenic Pulmonary Edema","longName":"5096251","preferredDefinition":"Pulmonary edema that is not a result of cardiac dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Noncardiogenic Pulmonary Edema","conceptCode":"C124947","definition":"Pulmonary edema that is not a result of cardiac dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28970750-C119-7F6B-E050-BB89AD437E53","latestVersionIndicator":"Yes","beginDate":"2016-01-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28970750-C132-7F6B-E050-BB89AD437E53","beginDate":"2016-01-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-05","modifiedBy":"ONEDATA","dateModified":"2016-01-05","deletedIndicator":"No"},{"value":"Erythrodermic rash","valueDescription":"Erythroderma","ValueMeaning":{"publicId":"5095791","version":"1","preferredName":"Erythroderma","longName":"5095791","preferredDefinition":"A generalized inflammatory cutaneous disorder characterized by erythema and desquamation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythroderma","conceptCode":"C39646","definition":"A generalized inflammatory cutaneous disorder characterized by erythema and desquamation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"28848C0D-BCAE-E6D4-E050-BB89AD434F09","latestVersionIndicator":"Yes","beginDate":"2016-01-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"28997AAC-B8BD-6D24-E050-BB89AD437051","beginDate":"2016-01-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-01-05","modifiedBy":"ONEDATA","dateModified":"2016-01-05","deletedIndicator":"No"},{"value":"Development of renal insufficiency","valueDescription":"Renal Failure","ValueMeaning":{"publicId":"5095719","version":"1","preferredName":"Renal Failure","longName":"5095719","preferredDefinition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2837D986-61CE-631F-E050-BB89AD4324FB","latestVersionIndicator":"Yes","beginDate":"2015-12-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2837D986-61E7-631F-E050-BB89AD4324FB","beginDate":"2015-12-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-31","modifiedBy":"ONEDATA","dateModified":"2015-12-31","deletedIndicator":"No"},{"value":"Development of hepatic dysfunction","valueDescription":"Liver Dysfunction","ValueMeaning":{"publicId":"4291760","version":"1","preferredName":"Liver Dysfunction","longName":"4291760","preferredDefinition":"A finding that indicates abnormal liver function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Dysfunction","conceptCode":"C50634","definition":"A finding that indicates abnormal liver function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-643D-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2837D986-61FC-631F-E050-BB89AD4324FB","beginDate":"2015-12-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-12-31","modifiedBy":"ONEDATA","dateModified":"2015-12-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008575","version":"1","preferredName":"Symptoms","preferredDefinition":"signs that a person has a condition or disease. Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain(NCI). ","longName":"SM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB883C03-CF97-2540-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-04-17","modifiedBy":"MSUPLEY","dateModified":"2004-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2780140","version":"1","preferredName":"Engraftment Syndrome Symptom Type","preferredDefinition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.:An indication that a person has a condition or disease.  Some examples of symptoms are headache, fever, fatigue, nausea, vomiting, and pain.:Type; a subdivision of a particular kind of thing.","longName":"C63324:C4876:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Engraftment Syndrome","conceptCode":"C63324","definition":"A toxicity of hematopoietic stem cell transplantation that manifests as fever, rash and pulmonary deterioration which becomes evident at marrow engraftment. It occurs unexpectedly and is occasionally fatal. It can occur after an autogeneic or an allogeneic hematopoietic cell transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Symptom","conceptCode":"C4876","definition":"Subjective evidence of disease perceived by the patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56172F89-770A-66E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"ONEDATA","dateModified":"2008-09-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56172F89-771B-66E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-04","modifiedBy":"KUMMEROA","dateModified":"2016-01-05","changeDescription":". Added 4 PVs for 2100r4. AK 1/5/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964902","version":"1","longName":"2100r1: 100 Days Post-HSCT Data","context":"NHLBI"},{"publicId":"2964922","version":"1","longName":"2200r1: 6 Month to 2 Year Post-HSCT Data","context":"NHLBI"},{"publicId":"2964923","version":"1","longName":"2300r1: Greater Than 2 Years Post-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedMedicalConditionResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"HPST_ES_engraft_syn_symp_typ","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the symptoms of engra","type":"Preferred Question Text","description":"Specify the symptoms of engraftment syndrome:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2782511","type":"BRIDG Mapping Path","description":"PerformedMedicalConditionResult.value(ANY->CD) WHERE PerformedObservation > DeinfedObservation.nameCode = \"examine for Engraftment Syndrome\"\"","url":null,"context":"NHLBI"},{"name":"Specify the symptoms of engraftment syndrome","type":"Alternate Question Text","description":"Specify the symptoms of engraftment syndrome","url":null,"context":"NHLBI"},{"name":"Specify the symptoms of engraftment syndrome","type":"Application Standard Question Text","description":"Specify the symptoms of engraftment syndrome","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"567C35E2-9190-4D2C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2008-09-09","modifiedBy":"MALUMK","dateModified":"2021-10-04","changeDescription":". .1/3/14mn-added Bridg info. System generated def displayed as alt def. Added PV for 2100r4. AK 1/5/16 Alt name \"engraft_syndrm_cls_yn\"  removed due to being used on CDE 2782516. AK 7/26/16. AQT added for 2100r. 04/05/2021 KMM. ALT name added for 2100r7. 10/04/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}